West Africa: What are US Biological Warfare Researchers Doing in the Ebola Zone?
and their Fort Detrick associates in the US biowarfare research
community, who have been operating in West Africa during the past
several years.
What exactly have they been doing?
Exactly what diagnostic tests have they been performing on citizens of Sierra Leone?
Why do we have reports that the government of Sierra Leone has recently told Tulane researchers to stop this testing?
Have Tulane researchers and their associates attempted any
experimental treatments (e.g., injecting monoclonal antibodies) using
citizens of the region? If so, what adverse events have occurred?
The research program, occurring in Sierra Leone, the Republic of
Guinea, and Liberia—said to be the epicenter of the 2014 Ebola
outbreak—has the announced purpose, among others, of detecting the
future use of fever-viruses as bioweapons.
Is this purely defensive research? Or as we have seen in the past, is
this research being covertly used to develop offensive bioweapons?
For the last several years, researchers from Tulane University have
been active in the African areas where Ebola is said to have broken out
in 2014.
These researchers are working with other institutions, one of which
is USAMRIID, the US Army Medical Research Institute of Infectious
Diseases, a well-known center for biowar research, located at Fort
Detrick, Maryland.
In Sierra Leone, the Tulane group has been researching new diagnostic tests for hemorrhagic fevers.
Note: Lassa Fever, Ebola, and other labels are applied to a spectrum of illness that result in hemorrhaging.
Tulane researchers have also been investigating the use of monoclonal
antibodies as a treatment for these fevers—but not on-site in Africa,
according to Tulane press releases.
Here are excerpts from supporting documents.
Tulane University, Oct. 12, 2012, “Dean’s Update: Update on Lassa Fever Research” (.pdf here):
five-year $7,073,538 grant from the National Institute of Health to fund
the continued development of detection kits for Lassa viral hemorrhagic
fever.
study the disease. Dr. Robert Garry, Professor of Microbiology and
Immunology, and Dr. James Robinson, Professor of Pediatrics, have been
involved in the research of Lassa fever. Together the two have recently
been able to create what are called human monoclonal antibodies. After
isolating the B-cells from patients that have survived the disease, they
have utilized molecular cloning methods to isolate the antibodies and
reproduce them in the laboratory. These antibodies have been tested on
guinea pigs at The University of Texas Medical Branch in Galveston and
shown to help prevent them from dying of Lassa fever…
being constructed in Sierra Leone at the Kenema Government Hospital.
When finished, it will be better equipped to assist patients affected by
the disease and will hopefully help to end the spread of it.” [The
Kenema Hospital is one of the centers of the Ebola outbreak.]
Here is another release from Tulane University, this one dated Oct. 18, 2007. “New Test Moves Forward to Detect Bioterrorism Threats.”
has been completed for the first diagnostic test kits that will aid in
bioterrorism defense against a deadly viral disease. Tulane University
researchers are collaborating in the project.
and immunology at Tulane University, is principal investigator in a
federally funded study to develop new tests for viral hemorrhagic
fevers.
developer and marketer of diagnostic test kits, announced that the first
test kits for detection of hemorrhagic fever have competed initial
clinical testing in West Africa.
grant awarded by the National Institutes of Health, involve work by
Corgenix in collaboration with Tulane University, the U.S. Army Medical
Research Institute of Infectious Diseases, BioFactura Inc. and
Autoimmune Technologies.
Sierra Leone continue to show amazing results,” says Robert Garry,
professor of microbiology and immunology at the Tulane University School
of Medicine and principal investigator of the grant.
will result in detection products that will truly have a meaningful
impact on the healthcare in West Africa, but will also fill a badly
needed gap in the bioterrorism defense.
conducted at the Mano River Union Lassa Fever Network in Sierra Leone.
Tulane, under contract with the World Health Organization, implements
the program in the Mano River Union countries (Sierra Leone, Liberia and
Guinea) to develop national and regional prevention and control
strategies for Lassa fever and other important regional diseases.
technology demonstrates that our collaboration is working,” says
Douglass Simpson, president of Corgenix. “We have combined the skills of
different parties, resulting in development of some remarkable test
kits in a surprisingly short period of time. As a group we intend to
expand this program to address other important infectious agents with
both clinical health issues and threat of bioterrorism such as ebola.”
The third document is found on the Sierra Leone Ministry of Health and Sanitation Facebook page (no login required), dated July 23 at 1:35pm. It lays out emergency measures to be taken. We find this curious statement: “Tulane University to stop Ebola testing during the current Ebola outbreak.”
Why? Are the tests issuing false results? Are they frightening the
population? Have Tulane researchers done something to endanger public
health?
In addition to an investigation of these matters, another probe needs
to be launched into all vaccine campaigns in the Ebola Zone. For
example. HPV vaccine programs have been ongoing. Vials of vaccine must
be tested to discover ALL ingredients. Additionally, it’s well known
that giving vaccines to people whose immune systems are already severely
compromised is dangerous and deadly.
Thanks to birdflu666.wordpress.com for discovering hidden elements of the Ebola story.
Jon Rappoport
The author of three explosive collections, THE MATRIX REVEALED, EXIT FROM THE MATRIX, and POWER OUTSIDE THE MATRIX, Jon was a candidate for a US Congressional seat in the 29th
District of California. He maintains a consulting practice for private
clients, the purpose of which is the expansion of personal creative
power. Nominated for a Pulitzer Prize, he has worked as an investigative
reporter for 30 years, writing articles on politics, medicine, and
health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other
newspapers and magazines in the US and Europe. Jon has delivered
lectures and seminars on global politics, health, logic, and creative
power to audiences around the world. You can sign up for his free emails
at www.nomorefakenews.com
Ακολουθήστε το infognomonpolitics.gr στο Google News και μάθετε πρώτοι όλες τις ειδήσεις που αφορούν τα εθνικά θέματα, τις διεθνείς σχέσεις, την εξωτερική πολιτική, τα ελληνοτουρκικά και την εθνική άμυνα.
Ακολουθήστε το infognomonpolitics.gr στο FacebookΑκολουθήστε τον Σάββα Καλεντερίδη στο Facebook
Ακολουθήστε τον Σάββα Καλεντερίδη στο Twitter
Εγγραφείτε στο κανάλι του infognomonpolitics.gr στο Youtube